BSE Prices delayed by 5 minutes ! Prices as on   Sep 18, 2025 - 3:35PM   ABB India 5434.6 [ 0.90% ]ACC 1860.15 [ 0.17% ]Ambuja Cements 579.9 [ -0.43% ]Asian Paints Ltd. 2480 [ -0.56% ]Axis Bank Ltd. 1130.5 [ 0.40% ]Bajaj Auto 9075 [ -0.13% ]Bank of Baroda 248.95 [ 1.26% ]Bharti Airtel 1937 [ -0.21% ]Bharat Heavy Ele 234.05 [ -0.09% ]Bharat Petroleum 325.4 [ 0.60% ]Britannia Ind. 6080.15 [ -0.21% ]Cipla 1577.3 [ 1.16% ]Coal India 393.15 [ -1.61% ]Colgate Palm. 2365 [ 0.75% ]Dabur India 536.25 [ 0.15% ]DLF Ltd. 782.95 [ -0.36% ]Dr. Reddy's Labs 1322.5 [ 0.88% ]GAIL (India) 180.9 [ -0.39% ]Grasim Inds. 2881 [ 0.58% ]HCL Technologies 1493.7 [ 0.84% ]HDFC Bank 977.35 [ 1.13% ]Hero MotoCorp 5375 [ 0.45% ]Hindustan Unilever L 2583.6 [ 0.61% ]Hindalco Indus. 750.15 [ 0.03% ]ICICI Bank 1422.9 [ 0.29% ]Indian Hotels Co 782.5 [ 0.29% ]IndusInd Bank 735.7 [ -0.41% ]Infosys L 1542 [ 1.25% ]ITC Ltd. 412.5 [ 0.78% ]Jindal Steel 1047 [ 1.31% ]Kotak Mahindra Bank 2055.75 [ 0.27% ]L&T 3686.35 [ 0.03% ]Lupin Ltd. 2050 [ 0.93% ]Mahi. & Mahi 3643.15 [ 0.27% ]Maruti Suzuki India 15802 [ 0.01% ]MTNL 45.25 [ 0.02% ]Nestle India 1210 [ 0.48% ]NIIT Ltd. 112.55 [ 0.45% ]NMDC Ltd. 76.82 [ 1.53% ]NTPC 336.9 [ 0.15% ]ONGC 235.85 [ -0.40% ]Punj. NationlBak 111.75 [ -0.18% ]Power Grid Corpo 289.75 [ 0.91% ]Reliance Inds. 1415.7 [ 0.15% ]SBI 853.5 [ -0.40% ]Vedanta 454.95 [ -0.24% ]Shipping Corpn. 218.35 [ -0.52% ]Sun Pharma. 1647.05 [ 1.65% ]Tata Chemicals 990.95 [ -1.41% ]Tata Consumer Produc 1127.7 [ -0.75% ]Tata Motors 712.7 [ -0.90% ]Tata Steel 172.1 [ 0.50% ]Tata Power Co. 393.5 [ -0.28% ]Tata Consultancy 3177 [ 0.13% ]Tech Mahindra 1550 [ 0.22% ]UltraTech Cement 12640 [ -0.60% ]United Spirits 1328.4 [ -0.70% ]Wipro 257 [ 1.12% ]Zee Entertainment En 116 [ -0.09% ]
BSE

MARKETS

News Details

( As on 11/09/2025 18:48)

USFDA Completes cGMP Audit of Cohance Lifesciences’ API Facility in Andhra Pradesh with Zero Observations

Cohance Lifesciences Ltd announced that the United States Food and Drug Administration (USFDA) has successfully completed a current Good Manufacturing Practices (cGMP) audit of its Active Pharmaceutical Ingredient (API) manufacturing facility (API Unit 1) at Jaggaiahpet, Andhra Pradesh.

The inspection, conducted from September 8 to September 11, 2025, concluded with zero Form 483 observations, indicating full compliance with USFDA standards.

The company stated that it remains committed to upholding the highest standards of quality and regulatory compliance across its operations and will continue to ensure the manufacture and supply of high-quality pharmaceutical products for global markets.